Bhutani MS, Ejaz S, Cazacu IM, Singh BS, Shafi M, Stroehlein JR, Mehran RJ, Walsh G, Vaporciyan A, Swisher SG , Hofstetter W
[PMC free article: PMC3745999] [PubMed: 23640492] 614
Batch: GF-AOD5-B241 Assay Content: 4.86 mg Purity: greater than 99.8 percent Identification by Spectrum: 986 Identification by Retention Time: 0.996 Molecular Ion Mass Identification: 1815 Da Bacterial Endotoxins: 0.009 EU/mg Total Aerobic Microbial Count: Not detected Total Yeast and Mold Count: Not detected Research Applications In controlled laboratory environments, AOD-9604 may be utilised in experimental models designed to investigate peptide signalling systems and molecular communication pathways
95 Due of its multiple pharmacological effects, metformin is likely to be one of the most promising agents for treating AIH
And usually sleeping long, theres other disease states associated with it, right
Nanotechnology delivers a therapeutic dose at a fraction of the weight